(Received 1 June 1976) By using a labelled ketone body, D-3-hydroxy[3-14C]butyrate, or a ketone-body precursor, L-[4,5-3H]Ieucine, preferential labelling of spinal-cord cholesterol was demonstrated. In contrast, the phospholipid fraction was more heavily labelled in the liver. In both tissues phosphatidylcholine was the major labelled complex lipid. Incorporation of both substrates into total lipid, on a tissue-weight basis, was appreciably greater for spinal cord.
Ketone bodies have been shown to be a major carbon source for biosynthesis of structural components and for energy production in the developing brain (Hawkins et al., 1971; Williamson & Buckley, 1973; Sokoloff, 1973; DeVivo et al., 1975) . They serve as physiological precursors of developing central-nervous-system lipid (Weng et al., 1973; DeVivo et al., 1973; Edmond, 1974; Patel et al., 1975) .
Developing spinal-cord cholesterol in particular is heavily labelled when radioactive 3-hydroxybutyrate is the precursor (Edmond, 1974) . Leucine, which is degraded to acetoacetate and acetyl-CoA, can also serve as a suitable lipid precursor in the central nervous system (Kabara & Okita, 1961; Kabara, 1964; Smith, 1974) . The specific contribution to lipid biosynthesis of that portion of the leucine molecule that ultimately is degraded to acetoacetate has not been previously tested in the central nervous system. Leucine labelled on C4 and C-5 positions with 3H, i.e. specifically labelling the portion going to acetoacetate, has been used as a cholesterol precursor in other tissues (Miettinen & Penttila, 1968 . It was found to be a better sterol precursor than acetate in muscle, intestine and kidney, but not liver (Miettinen & Penttila, 1971 Lipids were extracted (Folch et al., 1957) and fractionated on a silicic acid column (2cmxl5cm) (Rouser et al., 1967) . The neutral lipids were separated by t.l.c. with light petroleum (b.p. 30-60'C)/ diethyl ether/acetic acid (82:18:1, by vol.) as the solvent system. Galactolipid and phospholipid fractions from the silicic acid column were examined further by t.l.c. with chloroform/methanol/water (70:30:4, by vol.) as the solvent system. After the plates were developed by exposure to I2, the regions of interest were scraped directly into scintillation vials and counted for radioactivity (Jones et al., 1975) . Cholesterol dibromide derivatives were prepared by the method of Schwenk & Werthessen (1952) .
Results and Discussion
Because the rate at which labelled 3-hydroxybutyrate and leucine are incorporated into spinal-cord lipids has as yet not been determined, uptake of these two precursors was assessed after three different times (Table 1) stant by 2.5h when [4,5-3H] leucine was the precursor.
Galactolipid and phospholipid labelling in the spinal cord was complete by 2.5h after injection. Although the overall radioactive-lipid content fluctuated in the liver, the relative distribution of labelled material between the lipid classes was generally unchanged with both precursors. The neutral lipids derived from spinal cord contained mainly radioactive sterol (Table 2) In comparing the two precursors, leucine and 3-hydroxybutyrate, and their incorporation into lipids of developing spinal cord and liver, the principal observation is that both were preferentially used for spinal-cord sterol formation. Since the degradation of leucine involves 3-hydroxy-3-methylglutaryl-CoA as a necessary intermediate, the question of how much labelled leucine is being transformed into cholesterol by the liver and transported to the spinal cord, instead of biosynthesis in situ from leucine or from liver-derived acetoacetate, may be posed. The central nervous system, however, appears to acquire little of its sterol from the systemic circulation (Davison et al., 1959; Kritchevsky & Defendi, 1962; Svanberg, 1970) . The effect of an altered pool size of circulating substrates on incorporation should also be considered. On the basis of the concentration of 3-hydroxybutyrate present in the blood of 6-10-day-old rats (Page et al., 1971) , the amount of labelled 3-hydroxybutyrate administered increased the circulating pool by approx. 10%. The concentration of the leucine pool was essentially unaltered (Schimassek & Gevik, 1965) .
When leucine serves as a sterol precursor, its incorporation into cholesterol may not be entirely sensitive to feedback inhibition by cholesterol (Miettinen & Penttila, 1971 ). Control of 3-hydroxybutyrate use in sterol synthesis has not been examined. In view of the importance of ketone bodies, and possibly ketone-body precursors such as leucine, to the developing nervous system and their demonstrated role in cholesterol biosynthesis, their use requires further investigation.
